Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
42 Proben im Labor - Jetzt beginnt die spannendste Phase für diese Wolfram-Aktie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Tradegate
20.07.26 | 11:59
10,890 Euro
-3,80 % -0,430
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
10,62010,80020.07.
10,64010,74020.07.

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBioGaia AB (publ) GAAP EPS of SEK 1.02, revenue of SEK 440.9M1
BIOGAIA Aktie jetzt für 0€ handeln
FrBioGaia AB Ser. B Q2 Income Advances1
FrBioGaia Q2 2026 slides: 12% organic growth, margins reach 33%1
FrBioGaia AB: Interim Report January - June 2026122SECOND QUARTER 2026 Net sales amounted to SEK 440.9 million (404.7), an increase of SEK 36.2 million, an increase excluding currency effects of 12% (9% including currency effects). Net sales in the...
► Artikel lesen
02.07.Invitation to media and analyst briefing for BioGaia Q2 2026 report2
18.06.BioGaia AB's subsidiary introduces a complete skincare routine for babies and children450BioGaia AB's subsidiary, Biogaia New Sciences AB, is expanding its BioGaia® Skincare portfolio with two new products and an updated design across the full range. The expanded skincare line reinforces...
► Artikel lesen
11.05.Probiotika-Aktie BioGaia nähert sich Allzeithoch2
08.05.Dividendenbekanntmachungen (08.05.2026)16.198 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1057 EUR  ADIDAS AG  DE000A1EWWW0 - 2,8 EUR  ALLIANCE RESOURCE PARTNERS LP  US01877R1086  0...
► Artikel lesen
07.05.BioGaia AB: Bulletin from Annual General Meeting of BioGaia AB (publ)242The Annual General Meeting of BioGaia AB (publ) was held on 7 May 2026 at 4.00 pm at Klara Konferens & Happynings, Klarabergsviadukten 90, Stockholm, at which the shareholders passed the resolutions...
► Artikel lesen
07.05.BioGaia AB Ser. B Reveals Drop In Q1 Income2
07.05.BioGaia AB launches BioGaia Protectis Plus - next-generation patented probiotic drops2
07.05.BioGaia AB: Interim Management Statement January - March 2026320FIRST QUARTER 2026 Net sales amounted to SEK 372.6 million (366.3), an increase of SEK 6.3 million, an increase excluding currency effects of 15% (2% including currency effects). Net sales in the...
► Artikel lesen
30.04.Invitation to media and analyst briefing for BioGaia Q1 2026 report2
28.04.BioGaia AB research confirms effectiveness of patented LongevityGuard technology in extending probiotic shelf life387Researchers at BioGaia have published new scientific findings in the journal Food and Bioprocess Technology, demonstrating that BioGaia's patented LongevityGuard® technology significantly improves the...
► Artikel lesen
30.03.Notice to attend the Annual General Meeting of BioGaia AB (publ)1
30.03.BioGaia Annual and Sustainability Report 2025 published3
20.03.BIOGAIA: 10-year follow-up study shows infant probiotics are positively associated with a reduction of childhood functional abdominal pain2
17.03.BioGaia AB: BioGaia exercises option to acquire remaining shares in Nutraceutics368BioGaia exercises the option to acquire the remaining 20 percent of the shares in Nutraceutics, the parent company to BioGaia's exclusive distributor of BioGaia's own products in the USA. BioGaia...
► Artikel lesen
26.02.BioGaia AB extends long-standing distribution partnership with Ewopharma289BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies' successful collaboration to date and reflects a shared ambition...
► Artikel lesen
18.02.Probiotikahersteller BioGaia wächst weiter6
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1